Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ginsberg

Showing results (301-310 of 607) with videos related to

Pageof 61
Sort By:
Archives of Internal Medicine|February 18, 2003
Imaging characteristics of a novel technetium Tc 99m-labeled platelet glycoprotein IIb/IIIa receptor antagonist in patients With acute deep vein thrombosis or a history of deep vein thrombosisShannon M Bates, John Lister-James, Jim A Julian, et al.
Cancer|February 1, 1988
Responses to chemotherapy or chemohormonal therapy in advanced breast cancer patients treated previously with adjuvant chemotherapy. A subset analysis of CALGB Study 8081C G Kardinal, M C Perry, A H Korzun, et al.
Thrombosis and Haemostasis|February 21, 2014
New oral anticoagulants for stroke prevention in atrial fibrillation: impact of study design, double counting and unexpected findings on interpretation of study results and conclusionsNoel C Chan, Jeremy S Paikin, Jack Hirsh, et al.
Journal of Cardiothoracic and Vascular Anesthesia|March 4, 2000
A comparison of inhaled nitric oxide and milrinone for the treatment of pulmonary hypertension in adult cardiac surgery patientsA Solina, D Papp, S Ginsberg, et al.
Annals of Internal Medicine|July 17, 2001
Management of suspected deep venous thrombosis in outpatients by using clinical assessment and D-dimer testingC Kearon, J S Ginsberg, J Douketis, et al.
The British Journal of Radiology|August 7, 2019
Cardiothoracic manifestations of Erdheim-Chester diseaseJeeban Paul Das, Lola Xie, Chris C Riedl, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 29, 2004
Pharmacoeconomic analysis of fondaparinux versus enoxaparin for the prevention of thromboembolic events in orthopedic surgery patientsGeorge Dranitsaris, Susan R Kahn, Carmine Stumpo, et al.
Chest|April 1, 1990
Tissue plasminogen activator (rt-PA) vs heparin in deep vein thrombosis. Results of a randomized trialA G Turpie, M N Levine, J Hirsh, et al.
Lung Cancer (Amsterdam, Netherlands)|April 3, 2014
Vinorelbine and gemcitabine as second- or third-line therapy for malignant pleural mesotheliomaMarjorie G Zauderer, Samantha L Kass, Kaitlin Woo, et al.
The Journal of Pediatrics|March 23, 2010
Fatal familial lung disease caused by ABCA3 deficiency without identified ABCA3 mutationsW Adam Gower, Susan E Wert, Jennifer S Ginsberg, et al.
Pageof 61

Showing results (301-310 of 607) with videos related to

Sort By:
Pageof 61
Archives of Internal Medicine|February 18, 2003
Imaging characteristics of a novel technetium Tc 99m-labeled platelet glycoprotein IIb/IIIa receptor antagonist in patients With acute deep vein thrombosis or a history of deep vein thrombosisShannon M Bates, John Lister-James, Jim A Julian, et al.
Cancer|February 1, 1988
Responses to chemotherapy or chemohormonal therapy in advanced breast cancer patients treated previously with adjuvant chemotherapy. A subset analysis of CALGB Study 8081C G Kardinal, M C Perry, A H Korzun, et al.
Thrombosis and Haemostasis|February 21, 2014
New oral anticoagulants for stroke prevention in atrial fibrillation: impact of study design, double counting and unexpected findings on interpretation of study results and conclusionsNoel C Chan, Jeremy S Paikin, Jack Hirsh, et al.
Journal of Cardiothoracic and Vascular Anesthesia|March 4, 2000
A comparison of inhaled nitric oxide and milrinone for the treatment of pulmonary hypertension in adult cardiac surgery patientsA Solina, D Papp, S Ginsberg, et al.
Annals of Internal Medicine|July 17, 2001
Management of suspected deep venous thrombosis in outpatients by using clinical assessment and D-dimer testingC Kearon, J S Ginsberg, J Douketis, et al.
The British Journal of Radiology|August 7, 2019
Cardiothoracic manifestations of Erdheim-Chester diseaseJeeban Paul Das, Lola Xie, Chris C Riedl, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 29, 2004
Pharmacoeconomic analysis of fondaparinux versus enoxaparin for the prevention of thromboembolic events in orthopedic surgery patientsGeorge Dranitsaris, Susan R Kahn, Carmine Stumpo, et al.
Chest|April 1, 1990
Tissue plasminogen activator (rt-PA) vs heparin in deep vein thrombosis. Results of a randomized trialA G Turpie, M N Levine, J Hirsh, et al.
Lung Cancer (Amsterdam, Netherlands)|April 3, 2014
Vinorelbine and gemcitabine as second- or third-line therapy for malignant pleural mesotheliomaMarjorie G Zauderer, Samantha L Kass, Kaitlin Woo, et al.
The Journal of Pediatrics|March 23, 2010
Fatal familial lung disease caused by ABCA3 deficiency without identified ABCA3 mutationsW Adam Gower, Susan E Wert, Jennifer S Ginsberg, et al.
Pageof 61